Literature DB >> 18348712

The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase.

Nobuo Tsuboi1, Tadahiko Utsunomiya, Richard L Roberts, Hideyuki Ito, Keiko Takahashi, Masaharu Noda, Takamune Takahashi.   

Abstract

CD148 is a transmembrane tyrosine phosphatase that has been implicated in the regulation of cell growth and transformation. However, the signalling mechanisms of CD148 are incompletely understood. To identify the specific intracellular molecules involved in CD148 signalling, we carried out a modified yeast two-hybrid screening assay. Using the substrate-trapping mutant form of CD148 (CD148 D/A) as bait, we recovered the p85 regulatory subunit of PI3K (phosphoinositide 3-kinase). CD148 D/A, but not catalytically active CD148, interacted with p85 in a phosphorylation-dependent manner in vitro and in intact cells. Growth factor receptor and PI3K activity were also trapped by CD148 D/A via p85 from pervanadate-treated cell lysates. CD148 prominently and specifically dephosphorylated p85 in vitro. Co-expression of CD148 reduced p85 phosphorylation induced by active Src, and attenuated the increases in PI3K activity, yet CD148 did not alter the basal PI3K activity. Finally, CD148 knock-down by siRNA (short interfering RNA) increased PI3K activity on serum stimulation. Taken together, these results demonstrate that CD148 may interact with and dephosphorylate p85 when it is phosphorylated and modulate the magnitude of PI3K activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348712     DOI: 10.1042/BJ20071317

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase.

Authors:  Keiko Takahashi; Raymond L Mernaugh; David B Friedman; Rebecca Weller; Nobuo Tsuboi; Hironobu Yamashita; Vito Quaranta; Takamune Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 2.  Cellular biochemistry methods for investigating protein tyrosine phosphatases.

Authors:  Stephanie M Stanford; Vanessa Ahmed; Amy M Barrios; Nunzio Bottini
Journal:  Antioxid Redox Signal       Date:  2014-02-25       Impact factor: 8.401

3.  Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.

Authors:  Keiko Takahashi; Rachel H Kim; Lejla Pasic; Lilly He; Shinya Nagasaka; Daisuke Katagiri; Tracy May; Akira Shimizu; Raymond C Harris; Raymond L Mernaugh; Takamune Takahashi
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

4.  The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation.

Authors:  Sang Won Park; Yingjiang Zhou; Justin Lee; Allen Lu; Cheng Sun; Jason Chung; Kohjiro Ueki; Umut Ozcan
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

5.  Receptor type protein tyrosine phosphatases (RPTPs) - roles in signal transduction and human disease.

Authors:  Yiru Xu; Gary J Fisher
Journal:  J Cell Commun Signal       Date:  2012-08-01       Impact factor: 5.782

Review 6.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.

Authors:  Gabi Tarcic; Shlomit K Boguslavsky; Jean Wakim; Tai Kiuchi; Angela Liu; Felicia Reinitz; David Nathanson; Takamune Takahashi; Paul S Mischel; Tony Ng; Yosef Yarden
Journal:  Curr Biol       Date:  2009-11-17       Impact factor: 10.834

8.  Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases.

Authors:  Francesca Sacco; Michele Tinti; Anita Palma; Emanuela Ferrari; Aurelio P Nardozza; Rob Hooft van Huijsduijnen; Takamune Takahashi; Luisa Castagnoli; Gianni Cesareni
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

9.  Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells.

Authors:  Jasminka Omerovic; Michael J Clague; Ian A Prior
Journal:  Biochem J       Date:  2010-01-27       Impact factor: 3.857

10.  Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148.

Authors:  Konstantin Tsoyi; Sarah G Chu; Nasly G Patino-Jaramillo; Julie Wilder; Julian Villalba; Melanie Doyle-Eisele; Jacob McDonald; Xiaoli Liu; Souheil El-Chemaly; Mark A Perrella; Ivan O Rosas
Journal:  Am J Respir Cell Mol Biol       Date:  2018-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.